News & Updates

Influenza vaccine wards off cardiovascular events, death in CAD patients
Influenza vaccine wards off cardiovascular events, death in CAD patients
10 May 2023 byStephen Padilla

A meta-analysis of randomized trials has revealed that influenza vaccination is effective at preventing all-cause mortality, cardiovascular mortality, major acute cardiovascular events, and acute coronary syndrome (ACS) among patients with coronary artery disease (CAD), particularly in those with ACS.

Influenza vaccine wards off cardiovascular events, death in CAD patients
10 May 2023
Donanemab BLAZEs through Alzheimer’s treatment TRAIL in first active comparator trial
Donanemab BLAZEs through Alzheimer’s treatment TRAIL in first active comparator trial
10 May 2023 byAudrey Abella

The first study to directly compare two disease-modifying agents for Alzheimer’s disease (AD), the phase III TRAILBLAZER-ALZ 4 study shows promising efficacy and safety data on donanemab vs aducanumab for the treatment of early symptomatic AD.

Donanemab BLAZEs through Alzheimer’s treatment TRAIL in first active comparator trial
10 May 2023
Delaying treatment of glaucoma not necessarily harmful
Delaying treatment of glaucoma not necessarily harmful
10 May 2023

Withholding treatment in individuals with glaucoma does not appear to lead to serious consequences in terms of visual function, according to a study.

Delaying treatment of glaucoma not necessarily harmful
10 May 2023